Women and HIV: Get the Facts on HIV Testing, Prevention, and Treatment - fda.gov

Women and HIV: Get the Facts on HIV Testing, Prevention, and Treatment  fda.gov

London patient remains HIV-free after 2.5 years off treatment - Aidsmap

London patient remains HIV-free after 2.5 years off treatment  Aidsmap

A Hidden Defense Inside Llamas Could Be The Secret to Fighting HIV - ScienceAlert

A Hidden Defense Inside Llamas Could Be The Secret to Fighting HIV  ScienceAlert

WHO HIVResNet HIV drug resistance laboratory operational framework - World Health Organization (WHO)

WHO HIVResNet HIV drug resistance laboratory operational framework  World Health Organization (WHO)

Test and treat studies show high rates of HIV diagnosis, viral suppression - Aidsmap

Test and treat studies show high rates of HIV diagnosis, viral suppression  Aidsmap

Some children who start antiretrovirals very early may control HIV after stopping treatment - Aid...

Some children who start antiretrovirals very early may control HIV after stopping treatment  Aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV - Aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV  Aidsmap

Nearly a third of babies with HIV given ART very soon after birth have no HIV antibodies two year...

Nearly a third of babies with HIV given ART very soon after birth have no HIV antibodies two years later  Aidsmap

São Paulo patient experiences apparent viral rebound a year and a half after stopping HIV treatme...

São Paulo patient experiences apparent viral rebound a year and a half after stopping HIV treatment  Aidsmap

‘Molecular scissors’ successfully remove HIV genes from all tissues in infected monkeys - Aidsmap

‘Molecular scissors’ successfully remove HIV genes from all tissues in infected monkeys  Aidsmap

Sharing anti-HIV medication is common in rural Uganda - Aidsmap

Sharing anti-HIV medication is common in rural Uganda  Aidsmap

New cases of multi-drug resistant HIV becoming rarer in Europe - Aidsmap

New cases of multi-drug resistant HIV becoming rarer in Europe  Aidsmap

Child with HIV maintains viral suppression for three years off treatment - Aidsmap

Child with HIV maintains viral suppression for three years off treatment  Aidsmap

Long-acting injectable treatment maintains viral suppression - Aidsmap

Long-acting injectable treatment maintains viral suppression  Aidsmap

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment - Aidsmap

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment  Aidsmap

At-home support after HIV diagnosis in Uganda helps people get on ART and stick with it - Aidsmap

At-home support after HIV diagnosis in Uganda helps people get on ART and stick with it  Aidsmap

Yes, the same life expectancy as HIV-negative people, but far fewer years in good health - Aidsmap

Yes, the same life expectancy as HIV-negative people, but far fewer years in good health  Aidsmap

Experts shed light on coronavirus response and its implications for people with HIV - Aidsmap

Experts shed light on coronavirus response and its implications for people with HIV  Aidsmap

Have HIV-associated neurological disorders declined in people with HIV due to recent antiretrovir...

Have HIV-associated neurological disorders declined in people with HIV due to recent antiretrovirals?  Aidsmap

Two PEP doses spaced a week apart protect monkeys from injected HIV; one dose might work in human...

Two PEP doses spaced a week apart protect monkeys from injected HIV; one dose might work in humans  Aidsmap

Fostemsavir salvage therapy continues to look good at 96 weeks - Aidsmap

Fostemsavir salvage therapy continues to look good at 96 weeks  Aidsmap

Black MSM are 60% less likely to have suppressed HIV than white men in Atlanta - Aidsmap

Black MSM are 60% less likely to have suppressed HIV than white men in Atlanta  Aidsmap

The cornerstone of HIV treatment may be losing some of its power: will dolutegravir resistance be...

The cornerstone of HIV treatment may be losing some of its power: will dolutegravir resistance become a problem?  Aidsmap

Home tests aren’t an accurate way for people on HIV treatment to check they still have HIV - Aidsmap

Home tests aren’t an accurate way for people on HIV treatment to check they still have HIV  Aidsmap

The length of time Americans with HIV remain infectious is falling, but slowly - Aidsmap

The length of time Americans with HIV remain infectious is falling, but slowly  Aidsmap

People with HIV express high satisfaction with monthly injectable regimen - Aidsmap

People with HIV express high satisfaction with monthly injectable regimen  Aidsmap

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds...

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds  Aidsmap

Opportunistic infections remain common in people taking HIV treatment in Latin America - Aidsmap

Opportunistic infections remain common in people taking HIV treatment in Latin America  Aidsmap

“If we don’t include women in trials, we are not protecting women” – dolutegravir in pregnant wom...

“If we don’t include women in trials, we are not protecting women” – dolutegravir in pregnant women living with HIV  Aidsmap

The amber light: the World Health Organization’s position when an HIV viral load is “suppressed b...

The amber light: the World Health Organization’s position when an HIV viral load is “suppressed but not undetectable”  Aidsmap

Point-of-care viral load testing improves treatment outcomes and retention in care - Aidsmap

Point-of-care viral load testing improves treatment outcomes and retention in care  Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe - Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe  Aidsmap

Poor adherence associated with disruptive life events in young people living with HIV - Aidsmap

Poor adherence associated with disruptive life events in young people living with HIV  Aidsmap

Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for ...

Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for cause  Aidsmap

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women - Aid...

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women  Aidsmap

Diagnosis and treatment for high blood pressure need to be funded as part of HIV treatment progra...

Diagnosis and treatment for high blood pressure need to be funded as part of HIV treatment programmes  Aidsmap

Lower CD4 count and unsuppressed HIV raise the risk for severe COVID-19 - Aidsmap

Lower CD4 count and unsuppressed HIV raise the risk for severe COVID-19  Aidsmap

Fact check: List of US patents is not evidence that viruses are manmade - Reuters

Fact check: List of US patents is not evidence that viruses are manmade  Reuters

Viral suppression in Uganda improved by more viral load tests, done faster - Aidsmap

Viral suppression in Uganda improved by more viral load tests, done faster  Aidsmap